サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1338939

腱炎治療市場、シェア、市場規模、動向、産業分析レポート：治療法別、症状別、地域別、セグメント別予測、2023-2032年

Tendonitis Treatment Market Share, Size, Trends, Industry Analysis Report, By Treatment (Therapy and Surgery); By Condition; By Region; Segment Forecast, 2023-2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 114 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
腱炎治療市場、シェア、市場規模、動向、産業分析レポート：治療法別、症状別、地域別、セグメント別予測、2023-2032年
出版日: 2023年06月23日
発行: Polaris Market Research
ページ情報: 英文 114 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界の腱炎治療市場規模は2032年までに2,916億4,000万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

数種類のスポーツ関連傷害の負担の増加、新製品や新技術の絶え間ない革新、回復時間を短縮してより良い治療施設を提供する治療法、さらに世界各国の政府組織による取り組みの拡大が、市場成長を促進する主要因の1つとなっています。さらに、整形外科手術の高い普及率、確立されたヘルスケアインフラと治療施設の存在、および主要企業による製品ポートフォリオの拡大の実施は、世界市場をさらに大きなペースで刺激すると思われます。例えば、2022年11月、キャンバー・ファーマシューティカルズは新製品"Naproxen Oral Suspension"を追加しました。この新しく開発された製品は、腱炎の症状の治療に適応されています。

世界中の患者が、ダウンタイムを最小限に抑え、回復までの時間を短縮できる、より非侵襲的な治療法を求めるようになっており、理学療法、超音波療法、衝撃波療法といった治療法の需要を促進しています。さらに、腱の置換と再生技術における絶え間ない技術革新は、代替人工組織に対する需要の急増に対応し、市場にプラスの影響を与えています。患者の血小板を患部の腱に注入し、組織の修復を促すことで治癒を促進させるという新しい種類の治療法の普及率が著しく上昇しており、この治療法は肘、肩、膝の腱炎の治療で有望視されており、世界中で大きな人気と牽引力を獲得しています。

これとは別に、医療技術の急速な進歩に伴い、薬物療法、理学療法、手術など、腱炎に対するさまざまな種類の革新的な治療法が世界中で利用できるようになり、治療の効果や効率は高まっています。にもかかわらず、早期診断の重要性についての認識と普及が進んでおり、市場に大きな成長機会をもたらしています。

腱炎治療市場レポートハイライト

2022年の市場シェアは療法分野が最大を占めたが、これは主に、患者を安心させる能力と費用効率の高い選択肢としての人気による理学療法の採用によるものです。

ゴルファー肘分野は、人々のライフスタイルの絶え間ない変化とスポーツ活動への傾倒を背景に、予測期間中に最も高いCAGRで成長する見込みです。

北米地域は、人々の消費能力の増加、整備されたインフラの存在、医療技術企業とのコラボレーションへの高い浸透率により、2022年の世界市場で最大のシェアを占めました。

世界の主要市場プレイヤーは、Almatica Pharma、Teva Pharmaceuticals Industries、Abbott Laboratories、Stryker Corporation、Ingelheim Pharmaceuticals、Zimmer Biomet Holdingsです。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の腱炎治療市場に関する洞察

  • 腱炎治療市場- 業界スナップショット
  • 腱炎治療市場力学
    • 促進要因と機会
      • スポーツ外傷の増加
      • 腱炎治療の選択肢に対する意識の高まり
    • 抑制要因と課題
      • 新興国では保険適用範囲が限られている
  • PESTLE分析
  • 腱炎治療業界の動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界の腱炎治療市場、治療別

  • 主な調査結果
  • イントロダクション
  • 治療
  • 手術

第6章 世界の腱炎治療市場、症状別

  • 主な調査結果
  • イントロダクション
  • テニス肘
  • ゴルファーの肘
  • 投手の肘
  • ジャンパー膝
  • スイマーの肩
  • アキレス腱炎

第7章 世界の腱炎治療市場、地域別

  • 主な調査結果
  • イントロダクション
    • 腱炎治療市場評価、地域別、2019-2032年
  • 腱炎治療市場-北米
    • 北米：腱炎治療市場、症状別、2019～2032年
    • 北米：腱炎治療市場、治療別、2019～2032年
    • 腱炎治療市場-米国
    • 腱炎治療市場- カナダ
  • 腱炎治療市場- 欧州
    • 欧州：腱炎治療市場、症状別、2019～2032年
    • 欧州：腱炎治療市場、治療別、2019～2032年
    • 腱炎治療市場- 英国
    • 腱炎治療市場- フランス
    • 腱炎治療市場- ドイツ
    • 腱炎治療市場- イタリア
    • 腱炎治療市場- スペイン
    • 腱炎治療市場- オランダ
    • 腱炎治療市場- ロシア
  • 腱炎治療市場- アジア太平洋
    • アジア太平洋地域：腱炎治療市場、症状別、2019～2032年
    • アジア太平洋地域：腱炎治療市場、治療別、2019～2032年
    • 腱炎治療市場- 中国
    • 腱炎治療市場- インド
    • 腱炎治療市場- マレーシア
    • 腱炎治療市場- 日本
    • 腱炎治療市場- インドネシア
    • 腱炎治療市場- 韓国
  • 腱炎治療市場-中東およびアフリカ
    • 中東およびアフリカ：腱炎治療市場、症状別、2019～2032年
    • 中東およびアフリカ：腱炎治療市場、治療別、2019～2032年
    • 腱炎治療市場- サウジアラビア
    • 腱炎治療市場- アラブ首長国連邦
    • 腱炎治療市場- イスラエル
    • 腱炎治療市場- 南アフリカ
  • 腱炎治療市場-ラテンアメリカ
    • ラテンアメリカ：腱炎治療市場、症状別、2019～2032年
    • ラテンアメリカ：腱炎治療市場、治療別、2019～2032年
    • 腱炎治療市場- メキシコ
    • 腱炎治療市場- ブラジル
    • 腱炎治療市場- アルゼンチン

第8章 競合情勢

  • 拡張と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第9章 企業プロファイル

  • Teva Pharmaceuticals
  • Almatica Pharma
  • Abbott
  • Boehringer Ingelheim
  • Bayer
  • Merck
  • Pfizer
  • Teikoku Pharma
  • Stryker Corporation
  • 3M Company
  • Zimmer Biomet
  • AKSIGEN
  • DJO Global
  • AstraZeneca
  • GlaxoSmithKline
  • Camber Pharmaceuticals
  • CoNextions Inc
図表

List of Tables

  • Table 1 Global Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 2 Global Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 3 Tendonitis Treatment Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 4 North America: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 5 North America: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 6 U.S.: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 7 U.S.: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 8 Canada: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 9 Canada: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 10 Europe: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 11 Europe: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 12 UK: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 13 UK: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 14 France: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 15 France: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 16 Germany: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 17 Germany: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 18 Italy: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 19 Italy: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 20 Spain: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 21 Spain: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 22 Netherlands: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 23 Netherlands: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 24 Russia: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 25 Russia: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 26 Asia Pacific: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 27 Asia Pacific: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 28 China: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 29 China: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 30 India: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 31 India: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 32 Malaysia: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 33 Malaysia: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 34 Japan: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 35 Japan: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 36 Indonesia: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 37 Indonesia: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 38 South Korea: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 39 South Korea: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 40 Middle East & Africa: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 41 Middle East & Africa: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 42 Saudi Arabia: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 43 Saudi Arabia: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 44 UAE: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 45 UAE: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 46 Israel: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 47 Israel: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 48 South Africa: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 49 South Africa: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 50 Latin America: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 51 Latin America: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 52 Mexico: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 53 Mexico: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 54 Brazil: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 55 Brazil: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 56 Argentina: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 57 Argentina: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)

List of Figures

  • Figure 1 Global Tendonitis Treatment Market, 2019-2032 (USD Billion)
  • Figure 2 Integrated Ecosystem
  • Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4 Market by Geography
  • Figure 5 Porter's Five Forces
  • Figure 6 Market by Condition
  • Figure 7 Global Tendonitis Treatment Market, by Condition, 2022 & 2032 (USD Billion)
  • Figure 8 Market by Treatment
  • Figure 9 Global Tendonitis Treatment Market, by Treatment, 2022 & 2032 (USD Billion)
  • Figure 10 Tendonitis Treatment Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 11 Strategic Analysis - Tendonitis Treatment Market
目次
Product Code: PM3383

The global tendonitis treatment market size is expected to reach USD 291.64 billion by 2032, according to a new study by Polaris Market Research. The report "Tendonitis Treatment Market Share, Size, Trends, Industry Analysis Report, By Treatment (Therapy and Surgery); By Condition; By Region; Segment Forecast, 2023-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising burden of several types of sports-related injuries, constant innovations of new products and technologies, and treatment modalities to offer better treatment facilities with less recovery time, along with the growing efforts undertaken by government organizations worldwide, are among the leading factors driving the market growth. Moreover, the high prevalence of orthopedic procedures, and presence of well-established healthcare infrastructure and treatment facilities, and the implementation of product portfolio expansion by major players, will further stimulate the global market at a significant pace. For instance, in November 2022, Camber Pharmaceuticals added a new product, "Naproxen Oral Suspension." The newly developed product is being indicated to treat the symptoms of tendonitis.

Patients across the globe are increasingly seeking more non-invasive treatment options that offer minimal downtime and faster recovery times, which fuels the demand for therapies such as physical therapy, ultrasound therapy, and shockwave therapy. Additionally, the continuous innovations in tendon replacement and regeneration techniques address the surging demand for alternative engineered tissue and positively influence the market. There has been a significant rise in the penetration for a new kind of treatment, which involves injecting a patient's platelets into the affected tendon to promote healing that can stimulate tissue repair, and the therapy has shown promise in treating tendonitis in the elbow, shoulder, and knee, which is gaining huge popularity and traction all over the world.

Apart from this, with the rapid advances in medical technology, various types of innovative treatment options are available worldwide for tendonitis, including medications, physical therapy, and surgery, which led to increased effectiveness and efficiency of treatment. Despite this, there is an emerging prevalence and awareness regarding the importance of early diagnosis, which creates huge growth opportunities for the market.

Tendonitis Treatment Market Report Highlights

Therapy segment accounted for largest market share in 2022, which is mainly driven by adoption of physical therapy due to its ability to relive patients and its popularity as a cost-efficient option

Golfer's elbow segment is expected to grow at a highest CAGR during the anticipated period, on account of constant changes in people lifestyles and inclination towards sports activity

North America region dominated the global market with maximum share in 2022, owing to increase in people spending capacity, presence of well-developed infrastructure, and high penetration to collaborate with med-tech companies

The global key market players Almatica Pharma, Teva Pharmaceuticals Industries, Abbott Laboratories, Stryker Corporation, Ingelheim Pharmaceuticals, and Zimmer Biomet Holdings

Polaris Market Research has segmented the tendonitis treatment market report based on treatment, condition, and region:

Tendonitis Treatment, Treatment Outlook (Revenue - USD Billion, 2019 - 2032)

  • Therapy
  • Surgery

Tendonitis Treatment, Condition Outlook (Revenue - USD Billion, 2019 - 2032)

  • Tennis Elbow
  • Golfer's Elbow
  • Pitcher's Elbow
  • Jumper's Knee
  • Swimmer's Shoulder
  • Achille Tendonitis

Tendonitis Treatment, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Tendonitis Treatment Market Insights

  • 4.1. Tendonitis Treatment Market - Industry Snapshot
  • 4.2. Tendonitis Treatment Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing prevalence of sports injuries
      • 4.2.1.2. Growing awareness of tendonitis treatment options
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Insurance coverage is limited in emerging countries
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Tendonitis Treatment Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Tendonitis Treatment Market, by Treatment

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Tendonitis Treatment, by Treatment, 2019-2032 (USD Billion)
  • 5.3. Therapy
    • 5.3.1. Global Tendonitis Treatment Market, by Therapy, by Region, 2019-2032 (USD Billion)
  • 5.4. Surgery
    • 5.4.1. Global Tendonitis Treatment Market, by Surgery, by Region, 2019-2032 (USD Billion)

6. Global Tendonitis Treatment Market, by Condition

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • 6.3. Tennis Elbow
    • 6.3.1. Global Tendonitis Treatment Market, by Tennis Elbow, by Region, 2019-2032 (USD Billion)
  • 6.4. Golfer's Elbow
    • 6.4.1. Global Tendonitis Treatment Market, by Golfer's Elbow, by Region, 2019-2032 (USD Billion)
  • 6.5. Pitcher's Elbow
    • 6.5.1. Global Tendonitis Treatment Market, by Pitcher's Elbow, by Region, 2019-2032 (USD Billion)
  • 6.6. Jumper's Knee
    • 6.6.1. Global Tendonitis Treatment Market, by Jumper's Knee, by Region, 2019-2032 (USD Billion)
  • 6.7. Swimmer's Shoulder
    • 6.7.1. Global Tendonitis Treatment Market, by Swimmer's Shoulder, by Region, 2019-2032 (USD Billion)
  • 6.8. Achilles Tendonitis
    • 6.8.1. Global Tendonitis Treatment Market, by Achilles Tendonitis, by Region, 2019-2032 (USD Billion)

7. Global Tendonitis Treatment Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Tendonitis Treatment Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 7.3. Tendonitis Treatment Market - North America
    • 7.3.1. North America: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
    • 7.3.2. North America: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.3.3. Tendonitis Treatment Market - U.S.
      • 7.3.3.1. U.S.: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.3.3.2. U.S.: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.3.4. Tendonitis Treatment Market - Canada
      • 7.3.4.1. Canada: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.3.4.2. Canada: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • 7.4. Tendonitis Treatment Market - Europe
    • 7.4.1. Europe: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
    • 7.4.2. Europe: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.4.3. Tendonitis Treatment Market - UK
      • 7.4.3.1. UK: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.4.3.2. UK: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.4.4. Tendonitis Treatment Market - France
      • 7.4.4.1. France: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.4.4.2. France: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.4.5. Tendonitis Treatment Market - Germany
      • 7.4.5.1. Germany: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.4.5.2. Germany: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.4.6. Tendonitis Treatment Market - Italy
      • 7.4.6.1. Italy: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.4.6.2. Italy: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.4.7. Tendonitis Treatment Market - Spain
      • 7.4.7.1. Spain: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.4.7.2. Spain: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.4.8. Tendonitis Treatment Market - Netherlands
      • 7.4.8.1. Netherlands: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.4.8.2. Netherlands: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.4.9. Tendonitis Treatment Market - Russia
      • 7.4.9.1. Russia: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.4.9.2. Russia: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • 7.5. Tendonitis Treatment Market - Asia Pacific
    • 7.5.1. Asia Pacific: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
    • 7.5.2. Asia Pacific: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.5.3. Tendonitis Treatment Market - China
      • 7.5.3.1. China: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.5.3.2. China: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.5.4. Tendonitis Treatment Market - India
      • 7.5.4.1. India: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.5.4.2. India: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.5.5. Tendonitis Treatment Market - Malaysia
      • 7.5.5.1. Malaysia: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.5.5.2. Malaysia: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.5.6. Tendonitis Treatment Market - Japan
      • 7.5.6.1. Japan: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.5.6.2. Japan: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.5.7. Tendonitis Treatment Market - Indonesia
      • 7.5.7.1. Indonesia: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.5.7.2. Indonesia: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.5.8. Tendonitis Treatment Market - South Korea
      • 7.5.8.1. South Korea: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.5.8.2. South Korea: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • 7.6. Tendonitis Treatment Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
    • 7.6.2. Middle East & Africa: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.6.3. Tendonitis Treatment Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.6.4. Tendonitis Treatment Market - UAE
      • 7.6.4.1. UAE: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.6.4.2. UAE: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.6.5. Tendonitis Treatment Market - Israel
      • 7.6.5.1. Israel: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.6.5.2. Israel: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.6.6. Tendonitis Treatment Market - South Africa
      • 7.6.6.1. South Africa: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.6.6.2. South Africa: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • 7.7. Tendonitis Treatment Market - Latin America
    • 7.7.1. Latin America: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
    • 7.7.2. Latin America: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.7.3. Tendonitis Treatment Market - Mexico
      • 7.7.3.1. Mexico: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.7.3.2. Mexico: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.7.4. Tendonitis Treatment Market - Brazil
      • 7.7.4.1. Brazil: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.7.4.2. Brazil: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.7.5. Tendonitis Treatment Market - Argentina
      • 7.7.5.1. Argentina: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.7.5.2. Argentina: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Teva Pharmaceuticals
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Almatica Pharma
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Abbott
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Boehringer Ingelheim
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Bayer
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Merck
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Pfizer
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Teikoku Pharma
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Stryker Corporation
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. 3M Company
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Zimmer Biomet
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development
  • 9.12. AKSIGEN
    • 9.12.1. Company Overview
    • 9.12.2. Financial Performance
    • 9.12.3. Product Benchmarking
    • 9.12.4. Recent Development
  • 9.13. DJO Global
    • 9.13.1. Company Overview
    • 9.13.2. Financial Performance
    • 9.13.3. Product Benchmarking
    • 9.13.4. Recent Development
  • 9.14. AstraZeneca
    • 9.14.1. Company Overview
    • 9.14.2. Financial Performance
    • 9.14.3. Product Benchmarking
    • 9.14.4. Recent Development
  • 9.15. GlaxoSmithKline
    • 9.15.1. Company Overview
    • 9.15.2. Financial Performance
    • 9.15.3. Product Benchmarking
    • 9.15.4. Recent Development
  • 9.16. Camber Pharmaceuticals
    • 9.16.1. Company Overview
    • 9.16.2. Financial Performance
    • 9.16.3. Product Benchmarking
    • 9.16.4. Recent Development
  • 9.17. CoNextions Inc
    • 9.17.1. Company Overview
    • 9.17.2. Financial Performance
    • 9.17.3. Product Benchmarking
    • 9.17.4. Recent Development